← Open Payments lookup

ELIZABETH TREFZGER: Open Payments

NPI 1629060116 · FRONT ROYAL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$941 in 37 payments from 10 companies in 2025. Trend: 2023 $374 · 2024 $758 · 2025 $941

Food & beverage: $718Education: $223
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$354
Neurocrine BioSciences, Inc.6$118
ABBVIE INC.4$97
Otsuka America Pharmaceutical, Inc.4$92
Supernus Pharmaceuticals, Inc.5$86
Alkermes, Inc.4$83
Axsome Therapeutics, Inc.2$37
Janssen Pharmaceuticals, Inc2$31
E.R. Squibb & Sons, L.L.C.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: INGREZZA, UZEDY, VRAYLAR, Qelbree, ARISTADA, ABILIFY ASIMTUFII, Auvelity, INVEGA SUSTENNA.

Industry payments across VA — which companies pay providers there.